Different medicinal mushroom species carry different documented safety concerns, not just one shared “drug interaction” risk. Reishi has case reports of liver injury and bleeding, chaga has case reports of kidney damage from long-term use, cordyceps has documented effects on immunosuppressant dosing, and several species have almost no human safety data at all. This guide compares species side by side so you can see which specific mushroom is behind which specific concern, rather than treating “mushroom supplements” as one interchangeable category.
Warning Signs That Need Immediate Medical Attention
Stop the supplement and contact a doctor right away if you notice any of these while taking a mushroom product:
- Yellowing of the skin or eyes, dark urine, or unusual tiredness (possible liver injury)
- Decreased urination, swelling in the legs or face, or persistent lower back pain (possible kidney injury)
- Unusual bruising, nosebleeds, or bleeding that will not stop
- A widespread streaky or whip-like skin rash after eating undercooked mushrooms
- Signs of a severe allergic reaction, such as swelling of the face or throat, or trouble breathing
These are documented, though uncommon, reactions described in published case reports. This is general education, not a diagnosis of your symptoms.
Why This Guide Is Organized by Species, Not by Medication
Mushroom Health Benefits already has a guide to mushroom supplement drug interactions organized by medication category, covering blood thinners, immunosuppressants, and diabetes medications. That guide answers, “Which mushrooms should I worry about if I take this medication?”
This guide answers a different question: “What has actually been documented for this specific mushroom species?” Some species have case reports of organ injury that have nothing to do with a specific prescription drug. Others have almost no human safety data published at all. Knowing which is which matters before you assume every mushroom supplement carries the same level of risk.
Species Safety Comparison
Here is what published evidence shows for each species, side by side:
- Reishi (Ganoderma lucidum): Rare case reports of liver injury, including one fatal case, plus separate case reports of surgical bleeding. Evidence type: human case reports. Extra caution: people with liver disease, people on blood thinners, people scheduled for surgery.
- Cordyceps: Documented changes to immunosuppressant drug levels in transplant patients taking cyclosporine. Evidence type: human case reports and small clinical data. Extra caution: organ transplant recipients and others on immunosuppressants.
- Chaga: Case reports of oxalate-related kidney injury, including one case that progressed to kidney failure after long-term, high-dose use. Evidence type: human case reports. Extra caution: people with kidney disease or a history of kidney stones.
- Turkey Tail: A long history of human clinical trials, mainly in Japan, with few reported side effects; the concern with immune-suppressing drugs is theoretical. Evidence type: human clinical trials for the extract PSK, with a theoretical interaction concern. Extra caution: people on immunosuppressants (theoretical concern).
- Shiitake: Documented cases of a streaky skin reaction called flagellate dermatitis, mainly from raw or undercooked mushroom. Evidence type: human case reports. Extra caution: not medication-specific; relevant to raw or undercooked consumption.
- Lion’s Mane: No confirmed human drug-interaction case reports identified in the published literature. Evidence type: an evidence gap, with only theoretical blood sugar effects proposed. Extra caution: people on diabetes medication (theoretical, precautionary).
- Maitake: Blood glucose and blood pressure lowering shown in animal studies, with one small human report describing a possible blood-sugar-lowering effect. Evidence type: mostly animal studies, with limited human case-level data. Extra caution: people on diabetes or blood pressure medication.
A “theoretical” concern does not mean a species is proven safe. It means researchers have not published documented human cases either way. Absence of a case report is not the same as absence of risk.
Reishi: The Species With the Most Documented Concerns
Reishi has more published human case reports than most other medicinal mushroom species, and two separate concerns show up in that literature.
The first is liver injury. A small number of case reports describe people developing liver problems after starting reishi products, ranging from mild enzyme changes to, in one published case, fatal liver failure. Most of these reports could not fully rule out other causes, and some involved products that combined reishi with other herbs or alcohol use. Still, the pattern was consistent enough that reishi is flagged as a rare but real cause of liver injury in medical toxicology references.
The second is bleeding risk, which the drug interactions overview article covers in more depth. Both concerns point the same direction: reishi is the species where a person with liver disease, a bleeding disorder, or an upcoming surgery has the strongest documented reason for caution. More background on the compounds involved is in the reishi mushroom research profile.
Chaga: A Kidney Concern, Not a Classic Drug Interaction
Chaga’s main documented safety issue is not a medication interaction in the usual sense. It is a direct toxicity concern. Chaga is naturally high in oxalates, and published case reports describe people developing oxalate-related kidney damage after long-term, high-dose chaga use, including one case that progressed to kidney failure.
This matters most for people who already have reduced kidney function, a history of kidney stones, or who take other medications that are hard on the kidneys. It is a reason for extra caution independent of what prescription medications someone takes. More detail on chaga’s composition is in the chaga mushroom research profile.
Cordyceps and Turkey Tail: The Immune-System Species
Cordyceps and turkey tail both affect the immune system, which is why they come up around immunosuppressant medications.
Cordyceps has the stronger documented signal. Case reports and small clinical observations describe cordyceps use changing the blood levels of cyclosporine, an immunosuppressant used after organ transplants, in ways that required dose adjustments. Turkey tail’s main extract, PSK, has a long history of human clinical trials, mostly in Japan, with relatively few reported side effects in those trials. The concern with turkey tail is more theoretical: because it is designed to stimulate immune activity, it could in principle work against a drug meant to suppress the immune system, even though this specific combination has less direct human case data than cordyceps does.
Shiitake: A Food Reaction, Not a Prescription Drug Issue
Shiitake’s best-documented human safety issue is unrelated to medications. Eating raw or undercooked shiitake mushrooms has been linked to a distinctive, streaky skin reaction called flagellate dermatitis, described in multiple published case series. It typically appears within a day or two of eating the mushroom and resolves on its own. This is worth knowing, but it is a food-handling issue rather than a drug interaction, so it applies whether or not someone takes prescription medication.
Lion’s Mane and Maitake: The Species With the Thinnest Human Data
Lion’s Mane stands out for a different reason: the published literature does not currently show confirmed human case reports of drug interactions for it. The main theoretical concern, shared with several other species, is a possible blood-sugar-lowering effect that has not been well documented in human interaction studies. That absence of documented cases is not the same as a clean bill of safety. It reflects how little targeted interaction research has been done, more than it reflects certainty that no interaction exists.
Maitake sits in between. Animal studies, including research in diabetic rats, show it can lower blood glucose and blood pressure. One small human report described a possible blood-sugar-lowering effect in people with type 2 diabetes. This is preliminary, human case-level evidence, not a large clinical trial, but it is enough to justify caution for anyone on diabetes or blood pressure medication.
How to Read the Evidence Behind Each Claim
Not all the entries in this guide rest on the same kind of evidence, and that difference matters:
- Human case reports describe something that happened to a real patient, documented by a clinician. They show a concern is possible, not how common it is.
- Human clinical trials follow groups of people under controlled conditions and give a better sense of how often a reaction happens, though trial size and length still limit what can be concluded.
- Animal studies show a biological effect is possible in that animal model. They do not confirm the same effect happens in people at typical supplement doses.
- Theoretical concerns are based on how a compound is known to act in the body, without a published human case yet showing the interaction actually occurred.
The evidence hierarchy guide on this site explains these categories in more depth.
Extra-Caution Groups Across All Species
Regardless of which specific mushroom is involved, certain groups should talk to a clinician before starting any mushroom supplement:
- People with existing liver or kidney disease
- People taking blood thinners or antiplatelet medication
- Organ transplant recipients or anyone on immunosuppressant medication
- People with diabetes who take blood-sugar-lowering medication
- Anyone scheduled for surgery
- People who are pregnant or breastfeeding; see this site’s mushroom safety in pregnancy and breastfeeding guide for that topic specifically
A Simple Way to Check a Specific Species
- Identify the exact species in the product, not just “mushroom blend.” Labels often list the Latin name.
- Find that species in the comparison list above and note its strongest documented concern.
- Check whether that concern matches your own health conditions or medications.
- Bring the product label to a pharmacist or your prescribing clinician before starting it, especially if you fall into one of the extra-caution groups above.
- Watch for the warning signs listed at the top of this guide during the first few weeks of use.
Frequently Asked Questions
Which mushroom species has documented liver injury case reports?
Reishi is the species with published human case reports of liver injury, ranging from mild to, in one case, fatal. These reports are rare and often involved other factors, such as combination products or alcohol use, that could not be fully ruled out.
Can chaga mushroom supplements harm the kidneys?
Published case reports describe kidney damage linked to long-term, high-dose chaga use, caused by its naturally high oxalate content. This is a documented concern for people with existing kidney problems, independent of any specific medication.
Is lion’s mane mushroom safer than reishi or chaga?
Lion’s mane does not have confirmed human case reports of the kind published for reishi’s liver effects or chaga’s kidney effects. That is a difference in how much has been documented, not a guarantee of safety, since interaction research on lion’s mane is limited overall.
Does shiitake mushroom cause a skin reaction?
Yes. Eating raw or undercooked shiitake has been linked to a documented, temporary streaky skin rash called flagellate dermatitis. This is a food reaction, not a medication interaction, and it is unrelated to prescription drug use.
Educational Disclaimer
This article is for general education only. It summarizes published case reports, clinical trials, and animal research; it does not diagnose any condition, prescribe treatment, or guarantee that any mushroom supplement is safe for a particular person. Case reports show that a reaction is possible, not how likely it is for any individual. Always talk with a qualified clinician or pharmacist before starting, stopping, or changing any supplement, especially if you take prescription medication, have a liver or kidney condition, are pregnant or breastfeeding, or have surgery scheduled.